Labcorp
Labcorp Holdings Inc., operating under the brand name Labcorp, headquartered in Burlington, North Carolina, provides laboratory services used for diagnosis and healthcare decisions. It operates one of the largest clinical laboratory networks in the world and has operations in over 100 countries; although its operations are primarily in the U.S. Its Diagnostics Laboratories segment operates 2,000 patient service centers with more than 6,000 in-office phlebotomists in the United States. In addition to healthcare testing such as oncology testing, human immunodeficiency virus (HIV) genotyping and phenotyping, it provides testing for: employment, DNA testing to determine parentage and to determine immigration eligibility, environmental issues, wellness, toxicology, pain management, and medical drug monitoring. It also provides 50 tests that patients can complete at home. It processes over 160 million tests per year. Approximately 10% of this segment’s revenue are from the U.S. Medicare health insurance program. Its Biopharma Laboratory Services segment provides drug development, medical device and diagnostic development services to pharmaceutical, biotechnology, medical device, and diagnostic companies. In 2023, this division provided support to 84% of the new drugs and therapeutic products approved by the Food and Drug Administration. Labcorp performs its largest volume of specialty testing at its Center for Esoteric Testing in Burlington, North Carolina. Labcorp was an early pioneer of genomic testing using polymerase chain reaction (PCR) technology at its Center for Molecular Biology and Pathology in Research Triangle Park, North Carolina, where it also performs other molecular diagnostics. Labcorp operates the National Genetics Institute, Inc. (NGI), in Los Angeles, California, which develops PCR testing methods.
 Labcorp logo updated December 2020 | |
| Formerly | Laboratory Corporation of America Holdings |
|---|---|
| Company type | Public |
| Industry | Health care |
| Founded | September 5, 1978 (as Roche BioMedical) |
| Founder | Matthew Benger |
| Headquarters | Burlington, North Carolina, U.S |
Key people | Adam H. Schechter (president and CEO) |
| Services | Medical tests Medical laboratory |
| Revenue |
|
| |
| |
| Total assets |
|
| Total equity |
|
Number of employees | c. 70,000 (2024) |
| Website | labcorp.com |
| Footnotes / references [1] | |
Labcorp Holdings Inc., operating under the brand name Labcorp, headquartered in Burlington, North Carolina, provides laboratory services used for diagnosis and healthcare decisions.[1] It operates one of the largest clinical laboratory networks in the world and has operations in over 100 countries; although its operations are primarily in the U.S.[1]
Its Diagnostics Laboratories segment operates 2,000 patient service centers with more than 6,000 in-office phlebotomists in the United States. In addition to healthcare testing such as oncology testing, human immunodeficiency virus (HIV) genotyping and phenotyping, it provides testing for: employment, DNA testing to determine parentage and to determine immigration eligibility, environmental issues, wellness, toxicology, pain management, and medical drug monitoring. It also provides 50 tests that patients can complete at home. It processes over 160 million tests per year. Approximately 10% of this segment’s revenue are from the U.S. Medicare health insurance program.[1]
Its Biopharma Laboratory Services segment provides drug development, medical device and diagnostic development services to pharmaceutical, biotechnology, medical device, and diagnostic companies.[1] In 2023, this division provided support to 84% of the new drugs and therapeutic products approved by the Food and Drug Administration.[1]
Labcorp performs its largest volume of specialty testing at its Center for Esoteric Testing in Burlington, North Carolina.[2]
Labcorp was an early pioneer of genomic testing using polymerase chain reaction (PCR) technology at its Center for Molecular Biology and Pathology in Research Triangle Park, North Carolina, where it also performs other molecular diagnostics. Labcorp operates the National Genetics Institute, Inc. (NGI), in Los Angeles, California, which develops PCR testing methods.[3]
History
[edit]1971-2000
[edit]In 1971, Revlon acquired DCL BioMedical, a clinical laboratory business founded in 1968. In 1974, it changed its name to National Health Laboratories Incorporated. By 1977, it operated clinical testing laboratories in 13 cities and maintained auxiliary service centers and satellite laboratories in 15 other cities. In 1978, it acquired American Biomedical Corporation, giving it operations in the Southwestern United States and data processing technology. In 1985, Revlon was acquired by Ronald Perelman. Revlon divested its other businesses and a major stake in the company was acquired by MacAndrews & Forbes.[4]
In 1988, National Health Laboratories became a public company via an initial public offering on the NASDAQ exchange.[5]
In 1989, the company generated revenue of about US$400 million, with about US$70 million in earnings.[6]
In the early 1990s, worries about malpractice lawsuits led doctors to conduct more clinical testing before diagnosing, which increased business for the company.[4]
In 1990, the company's revenues reached US$500 million, with over US$70 million in earnings.[6]
In 1991, National Health Laboratories moved its listing from the NASDAQ to the New York Stock Exchange.[6]
In June 1992, the company offered to acquire Damon Corporation for $260 million in cash and stock.[7] However, the company was outbid by Corning Inc., which acquired Damon for $370 million.[8]
By 1993, the company had 22 major laboratories.[9]
On March 8, 1994, National Health Laboratories Inc. reorganized as a holding company, National Health Laboratories Holdings Inc.
In 1994, National Health Laboratories acquired Allied Clinical Laboratories.[10] The acquisition price was reduced to $204 million after federal officials issued subpoenas in an investigation of Medicare billing practices.[11][12][13]
In April 1995, Hoffmann-La Roche, a division of Roche, contributed Roche Biomedical Laboratories, Inc. and US$186.7 million in cash to National Health Laboratories Holdings, in exchange for 49.9% of the combined company.[14] Perelman received about US$100 million from the deal, which made the new company the largest blood-testing company in the United States.[9][10][15][16] The company changed its name to Laboratory Corporation of America Holdings and relocated its headquarters to Burlington, North Carolina.[9]
In July 1998, Labcorp acquired the Michigan-based laboratory division of Universal Standard Healthcare (UHCI) and made an equity investment in the company. Labcorp also became UHCI's clinical laboratory long-term testing provider[17] but terminated this agreement in March 1999.[18]
2000s
[edit]
In June 2000, Labcorp acquired the laboratory testing business of Pathology Medical Laboratories.[19][20]
In May 2001, Labcorp acquired Path Lab Holdings, the largest regional laboratory in New England.[21]
In June 2001, it acquired ViroMed, which specialized on clinical diagnostic testing in virology, molecular biology, serology, microbiology, mycology and mycobacteriology, as well as in tissue and eye bank testing.[22] In 2013, it closed the Viromed facility in Minnetonka, Minnesota and laid off 79 workers.[23]
In December 2001, Labcorp became the exclusive marketer for genomics and proteomics tests for breast cancer, colon cancer, melanoma, and hypertension made by Myriad Genetics.[24]
In March 2002, Roche sold its remaining interest in the company.[25]
In May 2002, Labcorp acquired Dynacare, a Canadian medical laboratory services company, for $480 million.[26][27]
In January 2003, Labcorp acquired Dianon, a provider of oncology and genomic diagnostic testing services, for $598 million in cash.[28][29][30]
In February 2005, the company acquired US Pathology Labs Inc., a provider of anatomical pathology and oncology testing services, for $155 million.[20][31]
In March 2005, Labcorp acquired Esoterix, a provider of specialty reference testing, for approximately $150 million in cash from Behrman Capital.[32][33]
In November 2006, Labcorp acquired Litholink, a kidney stone analysis laboratory.[33]
In January 2008, Labcorp acquired Tandem Labs, a contract research organization specializing in advanced mass spectrometry, immunoanalytical support, pharmacokinetics, and pharmacodynamics.[34][33]
In June 2009, Labcorp acquired Monogram Biosciences, a diagnostic lab specializing in HIV resistance testing, for approximately $155 million including debt.[35]
2010s
[edit]
In September 2010, Labcorp acquired Genzyme Genetics, formerly a division of Genzyme Corporation, with 9 testing laboratories and approximately 1,900 employees, for $925 million in cash.[36]
In February 2011, Labcorp acquired the assets of bankrupt Westcliff Medical Laboratory. The FTC challenged the acquisition but lost in court.[37][38][39]
In June 2011, Labcorp acquired Canadian central labs partner Clearstone from Czura Thornton, adding laboratories in China, France, Singapore and Canada, and the central laboratory protocol management system APOLLO CLPM.[40]
In November 2011, Labcorp acquired more than 90% of the shares of DNA testing company Orchid Cellmark for $85 million. To receive approval of the transaction from the Federal Trade Commission, Labcorp sold parts of Orchid's DNA paternity testing business to DNA Diagnostics Center.[41][42]
In May 2012, Labcorp Clinical Trials sold its European biological sampling kit building operation located in Hamburg to Marken.[43]
In August 2012, Labcorp acquired testing lab Medtox Scientific for $241 million.[44]
In September 2013, Labcorp acquired MuirLab, the clinical laboratory outreach business of John Muir Health.[45]
In November 2014, Labcorp acquired LipoScience, a developer of diagnostic tests based on nuclear magnetic resonance spectroscopy measuring heart disease risk, for $85 million.[46][47][48]
In December 2014, Labcorp acquired Bode Technology Group, a provider of forensic DNA analysis, DNA collection products, and relationship testing and the largest DNA forensic testing company in the U.S., from SolutionPoint International.[49][50][51]
In February 2015, Labcorp acquired Covance for $6.1 billion.[52][53]
In October 2015, Labcorp acquired Safe Foods International Holdings and its two operating companies, International Food Network and The National Food Laboratory, expanding its capabilities in food and beverage product-development and product-integrity.[54]
In March 2016, Labcorp acquired Pathology Inc., a provider of reproductive donor testing as well as anatomic, molecular and digital pathology services focused on women's health.[55]
In September 2016, Labcorp acquired Sequenom for $371 million including debt, expanding its operations in Europe and Asia.[56][57]
In October 2016, Labcorp acquired ClearPath Diagnostics, a provider of laboratory diagnostic services in the Northeastern United States, from Shore Capital Partners.[58][59]
In May 2017, Labcorp acquired Pathology Associates Medical Laboratories from Providence Health & Services and Catholic Health Initiatives.[60]
In September 2017, Labcorp acquired Chiltern, a contract research organization (CRO), for $1.2 billion, and contributed it to Covance.[61][62]
In 2019, Labcorp acquired Wellness Corporate Solutions, a workplace wellness company.[63]
2020s
[edit]During the COVID-19 pandemic, the company was one of the major developers and processors of COVID-19 testing. In March 2020, Labcorp received emergency use authorization from the FDA for a test for SARS-CoV-2.[64] In April 2020, the company developed the first COVID-19 test in which people were able to collect a sample at home.[65] In July 2020, the company was processing 165,000 COVID-19 tests per day.[66]
In December 2021, the company acquired Toxikon, a contract research organization developing non-clinical testing services.[67][68][69]
In February 2022, the company acquired Personal Genome Diagnostics and its liquid biopsy and tissue-based genomic product, for $450 million in cash plus a possible earn-out of an additional $125 million.[70][71][72]
Also in February 2022, Labcorp entered into agreements with Ascension, one of the nation’s largest Catholic and nonprofit health systems, to manage Ascension's hospital-based laboratories in ten states and purchase assets of the health system's outreach laboratory business.[73][74][75]
In June 2023, Labcorp completed the corporate spin-off of Fortrea.[76][77]
In August 2024, Labcorp acquired the assets of bankrupt Invitae for $234 million.[78]
In January 2026, it was announced that Labcorp had sold select assets of its early development medical device testing business to NAMSA, a medical device testing, clinical research, and regulatory consulting company. The transaction transferred Labcorp’s US-based biocompatibility, analytical testing, microbiological, and preclinical research services to NAMSA, enabling Labcorp to concentrate on its core preclinical drug development and chemical testing activities.[79]
Acquisition history
[edit]- Labcorp (Established as National Health Laboratories, Inc., 1978, then renamed National Health Laboratories Holdings Inc., 1994)
- Labcorp
- Laboratory Corporation of America Holdings (Est. 1995 through the merger of National Health Laboratories Holdings and Roche Biomedical Laboratories)
- National Health Laboratories Holdings Inc.(Merged 1995)
- Allied Clinical Laboratories, Inc. (1994)
- Roche Biomedical Laboratories, Inc. (1995)
- National Health Laboratories Holdings Inc.(Merged 1995)
- Universal Standard Healthcare, Laboratory division (1998)
- Pathology Medical Laboratories (2000)
- Path Lab Holdings Inc. (2001)
- ViroMed Inc. (2001)
- Dynacare (2003)
- Esoterix, Inc. (2005)
- Litholink Corporation (2006)
- Tandem Labs (2007)
- Monogram Biosciences (2009)
- Westcliff Medical Laboratory (2010)
- Genzyme Genetics (2010)
- Clearstone (2011)
- Orchid Cellmark (2011)
- Medtox Scientific (2012)
- MuirLab (2013)
- Covance (2015)
- Virtual Center Laboratory B.V. (2002)
- GFI Clinical Services (2005)
- Signet Laboratories, Inc. (2006)
- Medaxial (2014)
- Sciformix Corporation (2018)
- LipoScience (2014)
- Bode Technology Group, Inc. (2014)
- SolutionPoint International, Inc. (2014)
- Safe Foods International Holdings, LLC (2015)
- International Food Network
- The National Food Laboratory
- Pathology Inc. (2016)
- Sequenom (2016)
- ClearPath Diagnostics (2016)
- Pathology Associates Medical Laboratories (2017)
- Chiltern (2017)
- Toxikon (2021)
- Personal Genome Diagnostics (2021)
- Invitae (2024)
- Laboratory Corporation of America Holdings (Est. 1995 through the merger of National Health Laboratories Holdings and Roche Biomedical Laboratories)
- Labcorp
Controversies
[edit]Overbilling the government
[edit]In 1992, the company was one of the first to be prosecuted as part of Operation Labscam, a nationwide crackdown on fraud in the healthcare system initiated by the U.S. Attorney's Office in San Diego, California. The company and others were accused of routinely submitting false claims to Medicare and Medicaid for unnecessary tests on blood samples that physicians had never ordered. In addition, charges for the tests billed to the government were significantly higher than what the company charged private insurers.[80] That year, the company agreed to pay $111 million to settle claims.[81] In November 1996, the company agreed to pay a total of $182 million as a result of the investigation.[82]
In February 2023, the company paid $19 million to resolve allegations that it violated the False Claims Act of 1863 by its submission of false claims to Medicare.[83]
Conflicts of interest
[edit]In 2012, Labcorp was criticized for its practice of paying the salaries of genetic counselors in hospitals and doctors' offices, which is perceived to be a possible conflict of interest.[84]
Data breaches
[edit]In July 2018, Labcorp's servers were affected by a variant of the SamSam ransomware, with the goal of locking or disabling computers and servers to prevent access to data. The attack resulted in delays, but no data was believed to have been stolen. The malware was blocked on the network by midnight on July 14, 2018.[85][86][87]
Faulty paternity tests
[edit]Labcorp has been criticized over faulty paternity tests, many of which have resulted in lawsuits. The most notable case was the 2005 false accusation of Washington hairdresser Andre Chreky, who spent $200,000 and years in court proving, despite a false-positive test, that he was not the father. In the trial, it was determined that only five people at Labcorp reviewed data and made paternity determinations, including during 10 hour shifts that required making determinations every 4 minutes.[88]
Sharing of patient data
[edit]In 2024, Labcorp faced a class action lawsuit for allowing Google to collect confidential patient information such as appointments made and website login details.[89]
Labor concerns
[edit]Employees have criticized the company's productivity goals, in which they say volume and speed of work done is prioritized over quality. Labs face staffing shortages and employees say they are overworked.[90]
Labcorp has been criticized for its process of having all employees terminated upon hospital laboratory management acquisitions, and making them reapply with LabCorp, thereby losing accrued employee benefits, including employee eligibility for Public Service Loan Forgiveness (PSLF) in the case of non-profit hospitals.[91]
In 2024, Labcorp stated that its goal is to "operate the company in a non-union environment."[92] After Labcorp became the manager of laboratories of Legacy Health, outsourced laboratory personnel unionized with the Oregon Federation of Nurses and Health Professionals.[93]
Aircraft
[edit]Labcorp (ICAO: SKQ, call sign: SKYLAB) utilizes a fleet of 12 Pilatus PC-12 and a single Pilatus PC-24 aircraft on nightly runs from Burlington for use on the East Coast.[94] Prior to the acquisition of PC-12 aircraft Labcorp utilized seven PA-31-350s.
Notable employees
[edit]- Mark Elliott Brecher, retired Chief Medical Officer of LabCorp, Emeritus Professor University of North Carolina
References
[edit]- ^ a b c d e f "Laboratory Corp of America Holdings Annual Report for the Fiscal Year Ended December 31, 2024 (10-K)". U.S. Securities and Exchange Commission. February 25, 2025.
- ^ "Accreditation Case Study: Labcorp's Center for Esoteric Testing and the Atlantic Division Regional Laboratory". A2LA. March 28, 2024.
- ^ "Laboratory Corp of America Holdings · 8-K". SECInfo.com. December 4, 2001.
- ^ a b "National Health Laboratories Incorporated". Encyclopedia.com.
- ^ "Form 10-K - Item 1. Description Of Business". U.S. Securities and Exchange Commission. March 25, 1994.
- ^ a b c "National Health Laboratories Inc. reports earnings for Qtr to June 30". The New York Times. July 17, 1990.
- ^ Sims, Calvin (June 22, 1993). "COMPANY NEWS; National Health Labs To Buy Rival". The New York Times.
- ^ JOSHI, PRADNYA (June 29, 1993). "Corning Far Outbids Rival in Move to Acquire Damon : Health: Offer of more than $370 million, or $23 a share, is 44% higher than National Health's price. At stake is key market share in clinical labs industry". Los Angeles Times.
- ^ a b c "National Health Laboratories 1994 Current Report - Form 8-K". secdatabase.com. July 8, 1994.
- ^ a b FREUDENHEIM, MILT (December 15, 1994). "COMPANY NEWS; Blood-Testing Concerns Plan $1.79 Billion Merger". The New York Times.
- ^ Adelson, Andrea (June 9, 1994). "Company News;; Bid for Allied Clinical Is Cut After Investigation Widens". The New York Times.
- ^ "Allied Clinical to be sold". United Press International. May 4, 1994.
- ^ "National Health Labs Lowers Bid For Allied". The Pharma Letter. June 19, 1994.
- ^ "COMPANY NEWS; NATIONAL HEALTH-ROCHE BIOMEDICAL LINK SET". The New York Times. Associated Press. April 29, 1995.
- ^ "Roche Biomed And National Health Labs To Merge". The Pharma Letter. January 2, 1995.
- ^ "Merger: National Health Laboratories Holdings Inc". Chicago Tribune. December 14, 1994.
- ^ "LABCORP COMPLETES ACQUISITION OF CLINICAL LABORATORY DIVISION". News & Record. August 5, 1998.
- ^ "LabCorp ends service agreement with Michigan company". American City Business Journals. March 29, 1999.
- ^ "LABCORP ACQUIRES CALIFORNIA CLINICAL LAB". News & Record. May 4, 2000.
- ^ a b "LabCorp completes purchase of US Labs". American City Business Journals. February 4, 2005.
- ^ "Labcorp completes acquisition of Path Lab". American City Business Journals. May 1, 2001.
- ^ "LabCorp completes purchase of ViroMed". American City Business Journals. June 4, 2001.
- ^ "Minnetonka Lab Will Lay Off 79 Workers". Twin Cities Business Magazine. May 8, 2013.
- ^ Pollack, Andrew (December 5, 2001). "Company News; Myriad Genetics To Be Marketed By Laboratory Corp". The New York Times.
- ^ "Roche to sell Labcorp shares at $86.50 each". American City Business Journals. March 7, 2002.
- ^ Harrington, Matt (July 25, 2002). "LabCorp purchase of Dynacare complete; stock falls". American City Business Journals.
- ^ "Dynacare accepts offer from Labcorp". The Globe and Mail. The Canadian Press. May 10, 2002.
- ^ "LabCorp completes purchase of Dianon Systems". American City Business Journals. January 20, 2003.
- ^ "Labcorp Agrees to Buy Dianon for $598 Million". The Wall Street Journal. November 11, 2002.
- ^ "LabCorp Moves To Acquire Cancer-Genomic Diagnostic Firm". WRAL-TV. November 11, 2002.
- ^ "LabCorp Announces Definitive Agreement To Acquire US Pathology Labs, Inc" (Press release). PR Newswire.
- ^ "LabCorp Completes Acquisition Of Esoterix, Inc" (Press release). PR Newswire. October 19, 2005.
- ^ a b c "Laboratory Corp of America Holdings Annual Report for the Fiscal Year Ended December 31, 2007 (10-K)". U.S. Securities and Exchange Commission.
- ^ "LabCorp Announces Definitive Agreement to Acquire Tandem Labs". Wiley. March 1, 2008.
- ^ "LabCorp to Acquire Monogram Biosciences for $107M". GenomeWeb. Crain Communications. June 23, 2009.
- ^ "Labcorp to Buy Genzyme Genetics for $925M". GenomeWeb. Crain Communications. September 13, 2010.
- ^ Schoenberg, Tom (February 23, 2011). "LabCorp Can Complete Purchase of Westcliff, Judge Rules". Bloomberg News.
- ^ "FTC Challenges Labcorp's Acquisition of Rival Clinical Laboratory Testing Company" (Press release). Federal Trade Commission. December 1, 2010.
- ^ Aronson, Clifford H.; Stoll, Neal R. (March 3, 2011). "California District Court Denies Federal Trade Commission Request for a Preliminary Injunction in Medical Laboratory Merger Case". Skadden, Arps, Slate, Meagher & Flom.
- ^ "LabCorp Enters into Definitive Agreement to Acquire Clearstone Central Laboratories" (Press release). U.S. Securities and Exchange Commission. June 1, 2011.
- ^ "LabCorp Successfully Completes Tender Offer for Orchid Cellmark and Commences Subsequent Offering Period to Allow for Addi" (Press release). Business Wire. December 12, 2011.
- ^ "LabCorp Successfully Completes Tender Offer for Orchid Cellmark and Commences Subsequent Offering Period to Allow for Addi" (Press release). U.S. Securities and Exchange Commission. December 8, 2011.
- ^ "Marken Acquires European Kit Building Operation From Labcorp Clinical Trials" (Press release). PR Newswire. May 3, 2012.
- ^ "Labcorp Insists It's Doing the Buying For Now". Genetic Engineering & Biotechnology News. Mary Ann Liebert, Inc. August 1, 2012.
- ^ "John Muir Health Sells Clinical Laboratory Outreach Services to Labcorp" (Press release). John Muir Health. September 4, 2013.
- ^ "LABCORP COMPLETES ACQUISITION OF LIPOSCIENCE" (Press release). U.S. Securities and Exchange Commission. November 21, 2014.
- ^ Bracken, David (September 25, 2014). "LabCorp acquiring Raleigh-based LipoScience for $85.3M". The News & Observer.
- ^ McCarthy, Erin (September 25, 2014). "LabCorp to Acquire LipoScience for $85 Million". The Wall Street Journal.
- ^ "LabCorp Announces Acquisition of Bode Technology". Business Wire. December 5, 2014.
- ^ "LabCorp Acquires Bode Technology". GenomeWeb. Crain Communications. December 5, 2014.
- ^ "LabCorp acquires DNA testing company". Times-News. December 5, 2014.
- ^ "LabCorp Completes Acquisition of Covance" (Press release). Business Wire. February 19, 2015.
- ^ Serafino, Phil (November 3, 2014). "Labcorp to Buy Covance for $6.1 Billion to Add Drug R&D". Bloomberg News.
- ^ "Labcorp Acquires Safe Foods International Holdings" (Press release). Business Wire. October 23, 2015.
- ^ Covington, Owen (March 21, 2016). "LabCorp completes purchase of California lab firm". American City Business Journals.
- ^ "LabCorp Completes Sequenom Acquisition". GenomeWeb. Crain Communications. September 7, 2016.
- ^ "Labcorp to Acquire Sequenom for $371M". Genetic Engineering & Biotechnology News. Mary Ann Liebert, Inc. July 27, 2016.
- ^ "Shore Capital Partners Announces Sale of ClearPath Diagnostics" (Press release). Business Wire. October 4, 2016.
- ^ "Shore Capital Partners Sells ClearPath Diagnostics to LabCorp". The Wall Street Journal. October 4, 2016.
- ^ Maben, Scott (May 4, 2017). "Labcorp completes purchase of Spokane's PAML". The Spokesman-Review.
- ^ "LabCorp Completes Acquisition of Chiltern" (Press release). Business Wire. September 1, 2017.
- ^ Mukhopadhyay, Akankshita (July 31, 2017). "Labcorp to expand oncology offerings with $1.2 billion Chiltern buy". Reuters.
- ^ "Fiona Gathright Biography". AAE Speakers. Retrieved February 19, 2025.
- ^ Chakraborty, Shreyashi (March 19, 2020). "FDA Approves Abbott Laboratories Coronavirus Test, Company To Ship 150,000 Kits". International Business Times. Archived from the original on 20 March 2020.
- ^ Brodwin, Erin (April 21, 2020). "FDA greenlights first Covid-19 test with at-home sample collection". Stat.
- ^ Stankiewicz, Kevin (July 21, 2020). "LabCorp CEO says coronavirus in U.S. is spreading faster than it can add testing capacity". CNBC.
- ^ "Labcorp Completes Acquisition of Toxikon Corporation". Business Wire. December 3, 2021.
- ^ "Labcorp to acquire life science firm with $40M in annual revenues". WRAL-TV. November 18, 2021.
- ^ Park, Andrea (November 18, 2021). "Labcorp adds to drug development, device testing services with Toxikon buy". FierceBiotech.
- ^ "Labcorp Completes Acquisition of Personal Genome Diagnostics" (Press release). Business Wire. February 21, 2022.
- ^ Babcock, Stephen (December 23, 2021). "Personal Genome Diagnostics is set to be acquired by Labcorp for $450M". Technically Media.
- ^ Robertson, Marcus (February 22, 2022). "Labcorp acquires Personal Genome Diagnostics". Becker's Hospital Review.
- ^ "Labcorp Enters Comprehensive, Long-Term Laboratory Relationship With Ascension" (Press release). Business Wire. February 9, 2022.
- ^ Pifer, Rebecca (February 10, 2022). "Ascension inks strategic relationship with Labcorp, expanding testing capabilities". Industry Dive.
- ^ Johnson, Lillian (October 4, 2022). "Labcorp finalizes agreement with Ascension, will manage hospital's laboratories in 10 states". American City Business Journals.
- ^ "Labcorp Completes Spin-off of Fortrea" (Press release). PR Newswire. July 3, 2023.
- ^ Keenan, Joseph (July 6, 2023). "Fortrea completes spinoff from Labcorp, names new members of the board". FierceBiotech.
- ^ "Labcorp Finalizes Acquisition of Select Assets of Invitae" (Press release). PR Newswire. August 5, 2024.
- ^ Debbarma, Salong (2026-01-09). "NAMSA acquires Labcorp's medical device testing assets". Medical Device Network. Retrieved 2026-01-09.
- ^ "DOJ And HHS Highlight Latest Efforts To Fight Fraud By Clinical Laboratories" (Press release). United States Department of Justice. February 24, 1997.
- ^ Sims, Calvin (December 19, 1992). "Company to Pay $111 Million In Health-Claims Fraud Suit". The New York Times.
- ^ Glaser Jr., Richard S.; Peck, Gill P. (1997). "Successful LabCorp Settlement a Result of Operation LABSCAM". United States Attorneys' Bulletin. 45. HeinOnline: 31.
- ^ "Labcorp to Pay the United States $19 Million to Settle Allegations Under the False Claims Act" (Press release). United States Department of Justice. February 7, 2023.
- ^ Pollack, Andrew (July 13, 2012). "Conflict Potential Seen in Genetic Counselors". The New York Times.
- ^ Osborne, Charlie (April 30, 2020). "Investors sue LabCorp over security failures in light of data breach, ransomware attack". ZDNet.
- ^ Copeland, Rob; Evans, Melanie (July 19, 2018). "Medical Testing Giant Labcorp Hit by Ransomware Attack". The Wall Street Journal.
- ^ "FBI Aware Of 'Reports Of Ransomware Attack' Involving Labcorp Security Breach". WFMY-TV. July 17, 2018.
- ^ Jackman, Tom (August 21, 2005). "Paternity Suit Raises Doubts About DNA Tests". The Washington Post.
- ^ "Labcorp accused of sharing confidential patient information with Google". WSOC-TV. February 17, 2024.
- ^ Maiberg, Emanuel (November 9, 2023). "'Literally Impossible:' Labcorp Workers Say Productivity Goals Are Pushing Them to the Brink". 404 Media.
- ^ Reed, Kevin; White, Jerry (July 1, 2022). "Ascension St. John Hospital fires lab technicians after signing outsourcing contract with Labcorp". World Socialist Web Site.
- ^ Hayes, Elizabeth (May 6, 2024). "New group of Portland health care workers vote to form union". American City Business Journals.
- ^ McIntosh, Don (April 18, 2024). "Outsourced lab workers respond by unionizing". Northwest Labor Press.
- ^ Williamson, Sarah N. (January 15, 2016). "Fatal 2013 plane crash in Burlington likely caused by pilot disorientation". News & Record.
External links
[edit]- Official website
- Business data for Laboratory Corporation of America Holdings:
- Labcorp Profile at Wikinvest